Literature DB >> 16327443

Gastrointestinal stromal tumors: insights from a new familial GIST kindred with unusual genetic and pathologic features.

Ciarán O'Riain1, Christopher L Corless, Michael C Heinrich, Denise Keegan, Mihai Vioreanu, Donal Maguire, Kieran Sheahan.   

Abstract

Familial gastrointestinal stromal tumor (GIST) is a rare autosomal dominant genetic disorder. We report the second family to date with a germline point mutation in exon 17 of the KIT gene that leads to substitution of aspartic acid at position 820 with tyrosine (D820Y). One or more GISTs was documented in three generations of this kindred, and there was associated hyperplasia of the interstitial cells of Cajal (ICC). One affected family member complained of dysphagia and another suffered small intestinal diverticulosis with perforation, which may represent additional consequences of ICC hyperplasia. Diffuse and nodular ICC hyperplasia associated with the latter family member's small intestinal diverticulosis is illustrated, providing supportive functional and morphologic evidence for the ICC being the cell of origin of GISTs. Skin hyperpigmentation was not observed. Analysis of a 17-cm malignant GIST in the index patient revealed that it was hemi/homozygous for the germline D820Y mutation, indicating loss of the remaining wild-type KIT allele with tumor progression. Two smaller lesions from this patient were heterozygous for the mutation. This phenomenon has been observed in up to 8% of sporadic malignant GISTs but has not been documented in familial disease.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16327443     DOI: 10.1097/01.pas.0000173024.79852.08

Source DB:  PubMed          Journal:  Am J Surg Pathol        ISSN: 0147-5185            Impact factor:   6.394


  20 in total

1.  Mitotic recombination as evidence of alternative pathogenesis of gastrointestinal stromal tumours in neurofibromatosis type 1.

Authors:  Douglas R Stewart; Christopher L Corless; Brian P Rubin; Michael C Heinrich; Ludwine M Messiaen; Lisa J Kessler; Paul J Zhang; David G Brooks
Journal:  J Med Genet       Date:  2007-01       Impact factor: 6.318

2.  Desmoid tumor mimicking GIST recurrence.

Authors:  Nina Nandy; Wendy Garvin; Thalia L Mesologites; Joel S Silver; Constantin A Dasanu
Journal:  J Gastrointest Cancer       Date:  2014-12

3.  Characterization of various types of mast cells derived from model mice of familial gastrointestinal stromal tumors with KIT-Asp818Tyr mutation.

Authors:  Noriko Kajimoto; Norihiro Nakai; Mizuka Ohkouchi; Yuka Hashikura; Ning-Ning Liu-Kimura; Koji Isozaki; Seiichi Hirota
Journal:  Int J Clin Exp Pathol       Date:  2015-10-01

Review 4.  Gastrointestinal stromal tumours: origin and molecular oncology.

Authors:  Christopher L Corless; Christine M Barnett; Michael C Heinrich
Journal:  Nat Rev Cancer       Date:  2011-11-17       Impact factor: 60.716

5.  A nonrandom association of gastrointestinal stromal tumor (GIST) and desmoid tumor (deep fibromatosis): case series of 28 patients.

Authors:  A G Dumont; L Rink; A K Godwin; M Miettinen; H Joensuu; J R Strosberg; A Gronchi; C L Corless; D Goldstein; B P Rubin; R G Maki; A J Lazar; D Lev; J C Trent; M von Mehren
Journal:  Ann Oncol       Date:  2011-10-12       Impact factor: 32.976

6.  Gain-of-Function Mutations of Receptor Tyrosine Kinases in Gastrointestinal Stromal Tumors.

Authors:  K Isozaki; S Hirota
Journal:  Curr Genomics       Date:  2006       Impact factor: 2.236

7.  Coexistence of gastrointestinal stromal tumors with other neoplasms.

Authors:  Łukasz Liszka; Ewa Zielińska-Pajak; Jacek Pajak; Dariusz Gołka; Joanna Huszno
Journal:  J Gastroenterol       Date:  2007-08-24       Impact factor: 7.527

8.  Clinical presentations of gastric small gastrointestinal stromal tumors mimics functional dyspepsia symptoms.

Authors:  Qing-Xiang Yu; Zhan-Kun He; Jiang Wang; Chao Sun; Wei Zhao; Bang-Mao Wang
Journal:  World J Gastroenterol       Date:  2014-09-07       Impact factor: 5.742

Review 9.  Gastrointestinal stromal tumor: a bridge between bench and bedside.

Authors:  Toshirou Nishida; Tsuyoshi Takahashi; Yasuaki Miyazaki
Journal:  Gastric Cancer       Date:  2010-01-05       Impact factor: 7.370

10.  Optimizing imatinib mesylate treatment in gastrointestinal stromal tumors.

Authors:  Yixing Jiang; Lee Ming; Alberto J Montero; Eric Kimchi; Mehrdad Nikfarjam; Kevin F Staveley-O'Carroll
Journal:  Gastrointest Cancer Res       Date:  2008-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.